VEGFA and sarcoma: Receptors activated by a vascular endothelial growth factor (VEGF) and a platelet-derived growth factor (PDGF) and overexpressed in sarcoma, Breakpoin cluster region-Abelson Kinase (BCR-ABL) in myeloid leukemia, and JAK (Janus Kinases) are of oncology relevance as far as RTK and NRTK are concerned [1].